Annual SG&A
$76.59M$1.64M+2.19%
Summary
- Current Value
- As of today, RLAY annual SG&A is $76.59M, up +2.19% on
- Historical Performance
- RLAY annual SG&A is up +33.47% over the past 3 years, and up +457.36% over the past 5 years
- All-Time High Comparison
- RLAY annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- RLAY annual SG&A is +16.09% above its 3-year low of $65.98M reached on an earlier date
- Sector Comparison
- RLAY annual SG&A is higher than 79.95% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $76.59M | +2.2% | +33.5% | +457.4% | +765.0% | |
| Quarterly SG&A | $12.13M | -38.6% | -24.5% | -0.8% | +295.5% | |
| TTM SG&A | -$7.40B | -9778.0% | -10000.0% | -10000.0% | -10000.0% | |
| Price | $8.00 | +65.6% | -49.2% | -80.3% | – | |
| Annual Operating Expenses | $395.68M | -2.3% | +72.0% | +370.8% | +693.1% | |
| Annual Operating Profit | -$385.67M | -1.6% | -69.9% | -358.9% | -673.1% | |
| Annual D&A | $5.46M | +3.7% | +39.2% | +92.1% | +153.7% | |
| Annual Revenue | $10.01M | -60.8% | +230.4% | +100.0% | +100.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $76.59M | at high | |
| 5Y | $76.59M | at high | |
| All | $76.59M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $65.98M | N/A | +16.1% |
| 5Y | $38.59M | N/A | +98.5% |
| All | $8.86M | +765.0% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $76.59M | +2.2% | |
| $74.95M | +13.6% | |
| $65.98M | +15.0% | |
| $57.39M | +48.7% |
| Year | Value | Change |
|---|---|---|
| $38.59M | +180.8% | |
| $13.74M | +55.2% | |
| $8.86M | - |
FAQ
What is the current annual SG&A of RLAY?
As of today, RLAY annual SG&A is $76.59M
What is 1-year change in RLAY annual SG&A?
RLAY annual SG&A is up +2.19% year-over-year
What is 3-year change in RLAY annual SG&A?
RLAY annual SG&A is up +33.47% over the past 3 years
How far is RLAY annual SG&A from its all-time high?
RLAY annual SG&A is currently at its all-time high
How does RLAY annual SG&A rank versus sector peers?
RLAY annual SG&A is higher than 79.95% of companies in Healthcare sector
When is RLAY next annual earnings release?
The next annual earnings release for RLAY is on
Quarterly SG&A
$12.13M$1.50M-10.99%
Summary
- Current Value
- As of today, RLAY quarterly SG&A is $12.13M, down -10.99% on
- Historical Performance
- RLAY quarterly SG&A is down -38.59% year-over-year, and down -24.54% over the past 3 years
- All-Time High Comparison
- RLAY quarterly SG&A is currently -39.77% below its historical high of $20.14M set on
- 3-Year Low Comparison
- RLAY quarterly SG&A is at its 3-year low
- Sector Comparison
- RLAY quarterly SG&A is higher than 75.02% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $12.13M | -11.0% | -38.6% | -24.5% | -0.8% | |
| Annual SG&A | $76.59M | – | +2.2% | +33.5% | +457.4% | |
| TTM SG&A | -$7.40B | -10000.0% | -9778.0% | -10000.0% | -10000.0% | |
| Price | $8.00 | +30.9% | +65.6% | -49.2% | -80.3% | |
| Quarterly Operating Expenses | $79.64M | +4.1% | -16.2% | -2.8% | +123.1% | |
| Quarterly Operating Profit | -$80.39M | -4.6% | +16.6% | +2.7% | -119.6% | |
| Quarterly D&A | $748.00K | -25.4% | -45.3% | -27.6% | -18.1% | |
| Quarterly Revenue | $0.00 | -100.0% | 0.0% | -100.0% | 0.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $18.74M | -35.3% | |
| 3Y | $20.14M | -39.8% | |
| 5Y | $20.14M | -39.8% | |
| All | $20.14M | -39.8% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $12.13M | at low | |
| 3Y | $12.13M | at low | |
| 5Y | $12.13M | at low | |
| All | $3.07M | +295.5% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of RLAY?
As of today, RLAY quarterly SG&A is $12.13M
What is RLAY quarterly SG&A most recent change?
RLAY quarterly SG&A was down -10.99% on September 30, 2025
What is 1-year change in RLAY quarterly SG&A?
RLAY quarterly SG&A is down -38.59% year-over-year
How far is RLAY quarterly SG&A from its all-time high?
RLAY quarterly SG&A is currently -39.77% below its historical high of $20.14M set on June 30, 2024
How does RLAY quarterly SG&A rank versus sector peers?
RLAY quarterly SG&A is higher than 75.02% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
TTM SG&A
-$7.40B$297.59M-4.19%
Summary
- Current Value
- As of today, RLAY TTM SG&A is -$7.40B, down -4.19% on
- Historical Performance
- RLAY TTM SG&A is down -9778.05% year-over-year, and down -11456.56% over the past 3 years
- All-Time High Comparison
- RLAY TTM SG&A is currently -3804.99% below its historical high of -$189.48M set on an earlier date
- 3-Year Low Comparison
- RLAY TTM SG&A is at its 3-year low
- Sector Comparison
- RLAY TTM SG&A is higher than 4.94% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$7.40B | -10000.0% | -9778.0% | -10000.0% | -10000.0% | |
| Annual SG&A | $76.59M | – | +2.2% | +33.5% | +457.4% | |
| Quarterly SG&A | $12.13M | -11.0% | -38.6% | -24.5% | -0.8% | |
| Price | $8.00 | +30.9% | +65.6% | -49.2% | -80.3% | |
| TTM Operating Profit | -$327.09M | +4.7% | +17.2% | -11.1% | -180.5% | |
| TTM D&A | $4.29M | -12.6% | -22.0% | +7.3% | +23.0% | |
| TTM Revenue | $8.36M | 0.0% | -16.5% | +393.0% | +100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$6.46B | N/A | -14.6% |
| 3Y | -$3.79B | N/A | -95.4% |
| 5Y | -$1.30B | N/A | -469.5% |
| All | -$189.48M | N/A | -3805.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$7.40B | N/A | at low |
| 3Y | -$7.40B | N/A | at low |
| 5Y | -$7.40B | N/A | at low |
| All | -$7.40B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of RLAY?
As of today, RLAY TTM SG&A is -$7.40B
What is RLAY TTM SG&A most recent change?
RLAY TTM SG&A was down -4.19% on September 30, 2025
What is 1-year change in RLAY TTM SG&A?
RLAY TTM SG&A is down -9778.05% year-over-year
How does RLAY TTM SG&A rank versus sector peers?
RLAY TTM SG&A is higher than 4.94% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- RLAY Official Website www.relaytx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1812364/000119312525269601/0001193125-25-269601-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm
- RLAY Profile on Yahoo Finance finance.yahoo.com/quote/RLAY
- RLAY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlay